HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Papayannidis Selected Research

Azacitidine (5 Azacytidine)

7/2023Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy.
8/2021Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study.
10/2018Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia.
12/2016Efficacy of Azacitidine in the treatment of adult patients aged 65 years or older with AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Papayannidis Research Topics

Disease

37Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2024 - 11/2008
31Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2023 - 02/2008
13Philadelphia Chromosome
05/2024 - 12/2008
11Neoplasms (Cancer)
03/2023 - 12/2011
9Leukemia
05/2023 - 11/2008
7Residual Neoplasm
05/2024 - 05/2014
6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2021 - 11/2015
4Systemic Mastocytosis
03/2023 - 11/2018
3Hematologic Neoplasms (Hematological Malignancy)
03/2023 - 06/2019
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 08/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2018 - 08/2015
2Disease Progression
05/2024 - 08/2015
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
12/2023 - 01/2022
2Thrombocytopenia (Thrombopenia)
06/2015 - 06/2013
1Anemia
12/2023
1VEXAS syndrome
12/2023
1Cytokine Release Syndrome
03/2023
1Acute Kidney Injury (Acute Renal Failure)
03/2023
1Lung Diseases (Lung Disease)
01/2023
1Inflammation (Inflammations)
11/2022
1Bacterial Infections (Bacterial Infection)
06/2022
1Infections
06/2022
1Carcinogenesis
01/2022
1Asthenia
01/2022
1Exanthema (Rash)
01/2022
1COVID-19
01/2022
1Erythema
01/2022
1Aneuploidy (Aneuploid)
10/2021
1Tumor Lysis Syndrome
01/2021
1Lymphoma (Lymphomas)
12/2020
1Bronchiolitis Obliterans Syndrome
12/2018
1Graft vs Host Disease (Graft-Versus-Host Disease)
12/2018
1Mastocytosis
11/2018

Drug/Important Bio-Agent (IBA)

19Tyrosine Kinase InhibitorsIBA
05/2024 - 11/2008
7Cytarabine (Cytosar-U)FDA LinkGeneric
07/2021 - 12/2009
6Imatinib Mesylate (Gleevec)FDA Link
05/2024 - 09/2009
6Inotuzumab OzogamicinIBA
12/2023 - 11/2018
6Phosphotransferases (Kinase)IBA
01/2022 - 04/2011
5blinatumomabIBA
09/2023 - 06/2017
5Dasatinib (BMS 354825)FDA Link
08/2016 - 09/2009
4ponatinibIBA
05/2024 - 10/2018
4Azacitidine (5 Azacytidine)FDA Link
07/2023 - 12/2016
3venetoclaxIBA
01/2023 - 06/2022
3glasdegibIBA
07/2021 - 08/2015
3nelarabine (506U78)FDA Link
01/2021 - 08/2010
3Proteins (Proteins, Gene)FDA Link
10/2019 - 11/2015
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 12/2008
2Monoclonal AntibodiesIBA
07/2023 - 01/2021
2Aurora Kinase AIBA
03/2023 - 01/2022
2Asparaginase (Elspar)FDA Link
11/2022 - 08/2014
2SteroidsIBA
01/2022 - 01/2021
2DecitabineFDA Link
08/2021 - 01/2021
2nutlin 3IBA
04/2021 - 01/2016
2RG7388IBA
01/2021 - 05/2020
2Gemtuzumab (Mylotarg)FDA Link
09/2017 - 12/2009
2Core Binding Factors (Core-Binding Factor)IBA
09/2017 - 06/2015
2Clofarabine (Clolar)FDA Link
08/2016 - 12/2009
2Protein Isoforms (Isoforms)IBA
12/2008 - 11/2008
1Hemoglobins (Hemoglobin)IBA
12/2023
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2023
1enasidenibIBA
12/2023
1beta-LactamsIBA
03/2023
1Chimeric Antigen ReceptorsIBA
03/2023
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
03/2023
1Meropenem (Merrem)FDA LinkGeneric
03/2023
1AlbuminsIBA
01/2023
1Carnitine (L-Carnitine)FDA LinkGeneric
11/2022
1Semaphorins (Semaphorin)IBA
11/2022
1AntigensIBA
10/2022
1Polo-Like Kinase 1IBA
01/2022
1Cyclin B1IBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1daratumumabIBA
01/2022
1midostaurinIBA
01/2022
1ChromatinIBA
10/2021
1CohesinsIBA
10/2021
1fms-Like Tyrosine Kinase 3IBA
01/2021
1AdrenomedullinIBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2020
1Etoposide (VP 16)FDA LinkGeneric
07/2020
1Mitoxantrone (Novantrone)FDA LinkGeneric
07/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1Thomsen-Friedenreich antibodiesIBA
12/2018
1Tryptases (Tryptase)IBA
11/2018
1adavosertibIBA
01/2018
1Antineoplastic Agents (Antineoplastics)IBA
01/2018
1CI 22IBA
06/2017
1NucleotidesIBA
11/2016
1Mesylates (Mesylate)IBA
08/2016
1prexasertibIBA
08/2016
1Checkpoint Kinase 1IBA
08/2016
1RG7356IBA
05/2016

Therapy/Procedure

27Therapeutics
12/2023 - 02/2008
12Drug Therapy (Chemotherapy)
07/2023 - 10/2015
5Stem Cell Transplantation
05/2023 - 11/2012
3Hematopoietic Stem Cell Transplantation
12/2023 - 06/2017
2Transplantation
01/2022 - 12/2018
2Salvage Therapy
08/2021 - 12/2020
1Precision Medicine
01/2023
1Induction Chemotherapy
05/2016